GROW Small Cap Fund Outperforms Benchmarks in Q1 2026 on HROW Position

The fund returned 4.18% in Q1 2026, beating Russell 2000 Growth and hedge fund indices amid market volatility. GROW Small Cap Equity Long/Short Fund reported a 4.18% return in Q1 2026, surpassing the Russell 2000 Growth Index’s -2.80% and the HFRI Equity Hedge Index’s -0.2

The fund returned 4.18% in Q1 2026, beating Russell 2000 Growth and hedge fund indices amid market volatility.

GROW Small Cap Equity Long/Short Fund reported a 4.18% return in Q1 2026, surpassing the Russell 2000 Growth Index’s -2.80% and the HFRI Equity Hedge Index’s -0.24%. Long and short positions helped mitigate volatility linked to geopolitical tensions, including the Iran War.

The fund’s top holding, Harrow (HROW), closed at $42.41 on June 22, 2026, with a 24.11% one-month return and a 33.74% gain over the past year. Harrow’s market capitalization stands at $1.58 billion, though the fund noted a disconnect between earnings expectations and underlying growth.

GROW Funds covered its position in HROW during the quarter, citing valuation concerns despite the company’s focus on ophthalmic therapies and growth prospects.

Leave a Reply

Your email address will not be published. Required fields are marked *